Scilex Holding Co
SCLX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001820190
No open-market purchases or sales by Scilex Holding Co insiders were filed in the last 90 days; 73 institutions reported holding it in 13F filings for Q2 2026, worth $5.48M in total; no superinvestor holds it.
Other share classesSCLXW
13F holders, Q2 2025
Institutional positions in Scilex Holding Co as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 69
- −15 vs. Q1 2025
- Shares held
- 635.3K
- −661.4K (−51.0%) vs. Q1 2025Converted for a 1-for-35 split
- Total value
- $3.72M
- −$7.55M (−67.0%) vs. Q1 2025
- New holders
- 33
- 13 more added
- Sold out
- 48
- 18 more reduced
1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SCLX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 73 | $5.48M |
| Q1 2026 | 73 | $5.81M |
| Q4 2025 | 82 | $13.7M |
| Q3 2025 | 83 | $15.0M |
| Q2 2025 | 69 | $3.72M |
| Q1 2025 | 85 | $11.3M |
| Q4 2024 | 102 | $20.9M |
| Q3 2024 | 94 | $31.6M |
| Q2 2024 | 91 | $76.9M |
| Q1 2024 | 102 | $45.5M |
| Q4 2023 | 91 | $53.4M |
| Q3 2023 | 81 | $40.7M |
| Q2 2023 | 93 | $119.8M |
| Q1 2023 | 87 | $104.2M |
| Q4 2022 | 7 | $240.1K |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Scilex Holding Co; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Avantax Advisory Services, Inc. | 0 | $0 | 0.00% | −565−100.0% | Sold outConverted for a 1-for-35 split |
| Arizona State Retirement System | 0 | $0 | 0.00% | −512−100.0% | Sold outConverted for a 1-for-35 split |
| Virtus Investment Advisers, Inc. | 0 | $0 | 0.00% | −513−100.0% | Sold outConverted for a 1-for-35 split |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −452−100.0% | Sold outConverted for a 1-for-35 split |
| Busey Wealth Management | 0 | $0 | 0.00% | −437−100.0% | Sold outConverted for a 1-for-35 split |
| Handelsbanken Fonder AB | 0 | $0 | 0.00% | −319−100.0% | Sold outConverted for a 1-for-35 split |
| Ci Investments Inc. | 0 | $0 | 0.00% | −234−100.0% | Sold outConverted for a 1-for-35 split |
| S&T Bank | 0 | $0 | 0.00% | −157−100.0% | Sold outConverted for a 1-for-35 split |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −149−100.0% | Sold outConverted for a 1-for-35 split |
| Public Employees Retirement Association of Colorado | 0 | $0 | 0.00% | −135−100.0% | Sold outConverted for a 1-for-35 split |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −162−100.0% | Sold outConverted for a 1-for-35 split |
| Stephens Consulting, LLC | 0 | $0 | 0.00% | −7−100.0% | Sold outConverted for a 1-for-35 split |
| Trust Co of Vermont | 0 | $0 | 0.00% | −1−100.0% | Sold outConverted for a 1-for-35 split |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −0−100.0% | Sold outConverted for a 1-for-35 split |
| Van Eck Associates Corp | 0 | $0 | 0.00% | −46−100.0% | Sold outConverted for a 1-for-35 split |
| Covestor Ltd | 0 | $0 | 0.00% | −0−100.0% | Sold outConverted for a 1-for-35 split |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −0−100.0% | Sold outConverted for a 1-for-35 split |
| Credit Agricole S A | – | – | – | – | Not filed |